FDA Inspection 594627 — Allergan Sales LLC

Allergan Sales LLC — FEI 1523957

The FDA completed an inspection of Allergan Sales LLC on Jul 10, 2009 in Cincinnati, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 10, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cincinnati, OH (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121521 CFR 211.67(b)Written procedures not established/followed
180121 CFR 211.84(a)Components withheld from use pending release
188321 CFR 211.165(a)Testing and release for distribution
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.